This inventor holds 1 USPTO granted patent. Top assignee: General Electric Company. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Anitti Eljas Seppo: Innovator in Fish Dot Counting Technology
Introduction
Anitti Eljas Seppo is a notable inventor based in Altamont, NY (US). He has made significant contributions to the field of biological research through his innovative patent. His work focuses on enhancing the accuracy of chromosomal abnormality detection in cells, which is crucial for cancer research and diagnosis.
Latest Patents
Anitti holds a patent for a method and systems for cell-level fish dot counting. This invention relates to a computer-implemented method that improves the process of enumerating chromosomal abnormalities in cells using fluorescence in situ hybridization (FISH). The method involves overlaying images of a biological sample, which includes a nuclear counterstain mask and a FISH binary mask. The FISH binary mask is extracted using a multi-level extended h-maxima or h-minima technique. This innovative approach enhances the precision of FISH dot counting, making it a valuable tool in medical diagnostics.
Career Highlights
Anitti is currently employed at General Electric Company, where he applies his expertise in developing advanced technologies. His work at GE has allowed him to contribute to various projects that aim to improve healthcare outcomes through innovative solutions.
Collaborations
Anitti has collaborated with several talented individuals in his field, including Yousef Ahmed Al-Kofahi and Dirk Ryan Padfield. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.
Conclusion
Anitti Eljas Seppo's contributions to the field of biological research through his patented method for cell-level fish dot counting exemplify the impact of innovation in healthcare. His work not only advances scientific understanding but also enhances diagnostic capabilities in cancer research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
